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Early repolarization (ER) is a common electrocardiographic
ﬁnding and is diagnosed by the presence of a J-wave
amplitude of Z0.1 mV in Z2 contiguous inferior or lateral
leads of a standard 12-lead electrocardiogram (ECG), which
is manifested as QRS slurring or notching.1 The ER pattern is
observed in 1%–13% of cases in the general population and
is mainly thought to be benign.2 However, Haïssaguerre
et al3 have underlined the potential malignant role of an ER
pattern in idiopathic ventricular ﬁbrillation (VF) patients. Of
206 idiopathic VF cases and 412 controls, ER pattern was
more frequently present in patients with idiopathic VF than
in those in the control group (31% vs 5%). In addition, a
population-based study from Finland including 10.864
middle-aged people found an ER pattern in 630 individuals
leading to an increased risk of cardiac death.4 An ER pattern
on the ECG in patients resuscitated from VF is called early
repolarization syndrome (ErS).1
So far, variants in several ion-channel genes have been
associated with ErS. Variants in KCNJ8 are associated with a
gain of function with an increased outward potassium
current,5,6 and variants in the subunits of the cardiac
L-type calcium channel (CACNA1C, CACNB2, CACNA2D1)
lead to a reduced inward calcium current.7 Finally, a variant in
SCN5A causes a loss of function of the sodium channel, which
leads to decreased inward sodium current.8KEYWORDS Early repolarization; J-wave syndrome; Ventricular ﬁbrillation;
Genetics; Ankyrin
ABBREVIATIONS ANK2 ¼ ankyrin-2 gene; ECG ¼ electrocardiogram;
EP ¼ Electrophysiology; ER ¼ early repolarization; ErS ¼ early
repolarization syndrome; ICD ¼ implantable cardioverter-
defibrillator; LVEF ¼ left ventricular ejection fraction; PVC ¼
premature ventricular contraction; VF ¼ ventricular fibrillation
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intermittent ER pattern and a potential recognized associa-
tion with variants in the ankyrin-2 gene (ANK2).
Case report 1
A 29-year-old man with a previous medical history of
meningitis collapsed in his home. He had family history of
sudden cardiac death. The paramedics arrived 3 minutes later
and used direct current cardioversion to convert a VF to sinus
rhythm. On his arrival at the hospital, echocardiography
results were normal with left ventricular ejection fraction
(LVEF) 460%. Coronary angiogram was normal without
atherosclerosis. The patient was subjected to 24 hours of
hypothermia treatment, with a target temperature of 331C. A
12-lead ECG recorded after hypothermia treatment, during
normal body temperature, showed inferior-lateral QRS
slurring (Figure 1).
Repeated VF episodes during intensive care were
observed, and amiodarone was started with apparent effect.
Before discharge, an implantable cardioverter-deﬁbrillator
(ICD) was implanted.
Twelve days later, the patient was readmitted to hospital
because of appropriate shock therapies from the ICD that
resulted from repeated VF episodes. During the next 18 days
in the hospital, he had 6 more episodes of VF. All episodes
were preceded by a premature ventricular contraction (PVC)
(Figure 2). Medical antiarrhythmic therapy was sequentially
tested with amiodarone (initial 600 mg twice a day, reduced
to 200 mg once a day), sotalol (160 mg twice a day),
metoprolol (75 mg/d), and ﬂecainide (100 mg twice a day),
but recurrent arrhythmia was observed with each of these
drugs. Combinations of antiarrhythmic drugs were not
tested.
Because of treatment-resistant VF, the patient was offered
radiofrequency ablation to eliminate the focus for the
monomorphic PVCs. The procedure seemed successful in
suppressing the PVCs, but on reentering the ward, the patient
had recurrent VF storm. He was readmitted to the EP
laboratory for supplementary radiofrequency ablation.pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.05.008
KEY TEACHING POINTS
 Isoproterenol and quinidine sulfate seems highly
effective in suppressing malignant arrhythmias in
patients with early repolarization syndrome.
 Radiofrequency catheter ablation doesn’t seem to
be an effective treatment for this type of
arrhythmia.
 Ankyrin variants may be an underlying cause of
early repolarization syndrome.
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despite the ablation attempt, intravenous isoproterenol infu-
sion was started, which completely suppressed the malignant
arrhythmias. The isoproterenol infusion was gradually
reduced and replaced with quinidine sulfate 300 mg twice
a day. The rhythm stabilized on quinidine sulfate treatment,
and the ER pattern in the ECG was markedly reduced.
During a 36-month follow-up period on quinidine sulfate, no
arrhythmias have been observed.
Case report 2
A 20-year-old man without known heart disease was
hospitalized after cardiac arrest. He had no previous
medical history and no family history of sudden cardiac
death. He collapsed in his home with cardiac arrest,
and basic resuscitation was started immediately. TheFigure 1 Case 1: A 12-lead electrocardiogram with inferolateral early repolar
treatment (red arrow).paramedics arrived 10 minutes later and used direct current
cardioversion to convert a VF. Return of spontaneous
circulation was achieved after 1 hour of resuscitation.
Results from coronary angiography and computed tomog-
raphy of the cerebrum were normal. Laboratory ﬁndings
revealed normal plasma potassium, sodium, calcium, and
magnesium levels at admission and after 24 hours of
hypothermia treatment with a target temperature of 331C.
An initial echocardiogram showed globally reduced con-
traction and LVEF of 20% with normal dimensions of left
and right ventricles. The next morning, a 12-lead ECG
showed an aggressive ER pattern in the inferior-lateral
leads (Figure 3A). One hour later, the patient had recurrent
VF, progressing into VF storm.
Initially, he was treated with intravenous magnesium and
amiodarone without any antiarrhythmic effect. After the start
of isoproterenol infusion, the tendency to malignant arrhyth-
mias ceased, and the ER pattern in the ECG was markedly
reduced (Figure 3B). Echocardiography during isoproterenol
infusion showed an LVEF of 55%, and on the second day
after the infusion was discontinued, the LVEF was estimated
at 35%. On the fourth day, cardiac magnetic resonance
scanning was performed using late gadolinium enhancement,
and the scans showed normal biventricular function, no
myocardial edema, and normal cardiac tissue. An echocar-
diogram 1 month after discharge showed normal myocardial
contraction with an LVEF of 60%. The reduced LVEF
observed at admission likely was due to myocardial
stunning.ization pattern with J-point elevation and QRS slurring after hypothermia
Figure 2 Case 1: Telemetry tracing. Ventricular ﬁbrillation preceded by a ventricular extrasystole.
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period without antiarrhythmic therapy, no arrhythmias have
been observed.Targeted next-generation DNA testing
Both patients were offered molecular genetic screening with
a panel of 75 genes. For a full list of genes sequenced, see
http://dx.doi.org/http://moma.dk/genetic-analysis, MOMA
NGS Heart panel v1.
Genomic DNA was puriﬁed from blood, and concen-
tration was measured with Invitrogen Quant-iT Picogreen
(Thermo Fisher Scientiﬁc, Waltham, MA); 1 µg was used for
TruSeq library preparation according to the manufacturer’s
instructions (Illumina, San Diego, CA). Libraries were
quantiﬁed by Kapa quantitative polymerase chain reaction
(Kapa Biosystems, Wilmington, MA). Targeting of the 75
genes was performed using the NimbleGen EZ Choice in-
solution capture system (Roche, Basel, Switzerland) follow-
ing the manufacturer’s protocol. Paired-end sequencing (2
150 base pairs) was performed on the Illumina MiSeq
desktop sequencer.
Data were imported into the CLC Genomics Workbench
6.0 (Aarhus, Denmark). Reads were trimmed for low-quality
bases, ambiguous bases, and adaptor sequence followed by
mapping to Hg19. After duplicate-read removal, variants
were called with the probabilistic variant detector requiring a
read coverage of at least 30 and a probability of 90. Variants
were uploaded to the Cartagenia Bench Lab NGS (Leuven,
Belgium) and ﬁltered using the following criteria: all variants
were ﬁltered against ESP6500 and 1000 genomes discarding
all variants present in 410% in any of these cohorts.
Furthermore, variants seen in 45% of samples in our in-
house database were also excluded. Potential splice-site
variants were kept, along with all exonic variants that were
not synonymous.
Next-generation sequencing revealed no variation in
known ErS-related genes but elucidated 2 variations in the
ankyrin-2 gene (ANK2). In the ﬁrst case, an ANK2 missense
variant was found at a highly conserved position
(c.9854T4C, p.Ile3285Thr, NM_001148.4), and 3 in silico
programs (SIFT, PolyPhen2, and Mutation Taster) predict it
to be disease causing. In case 2, an ANK2 missense variant
was found (c.11791G4A, p.Glu3931Lys, NM_001148.4)
that has been shown to reduce the function of ANK2 in
neonatal mouse cardiomyocytes.9 Frequencies for the
reported variants in the Exome Aggregation Consortium
(ExAC) database are 0.008228 (c.9854T4C, p.Ile3285Thr,NM_001148.4) in case 1, and 0 (c.11791G4A, p.
Glu3931Lys, NM_001148.4) in case 2.Discussion
In case 2, the ECGs (Figures 3A and 3B) were recorded
while the patient was receiving postresuscitation hypother-
mia treatment for 24 hours, with a target temperature of
331C. The large J waves in the precordial leads (Figure 3A)
could resemble Osborn waves, which is the most striking
feature of hypothermia.10 The ECG shown in Figure 3A was
recorded 4 hours after hypothermia treatment was started,
and only 1 hour before the patient developed VF. The ECG
demonstrated prominent J waves in both the lateral and
inferior leads. The ECG shown in Figure 3B was recorded
after 12 hours of hypothermia treatment and after the patient
had experienced VF and isoproterenol infusion had been
started. In this instance, the patient’s ECG was normalized,
and the arrhythmias were completely suppressed due to
intravenous isoproterenol infusion. These observations were
made during continued hypothermia treatment. Isoproterenol
was discontinued after the patient had regained normal body
temperature. Although Osborn waves mainly are apparent
during severe hypothermia (o301C), similar electrocardio-
graphic changes and VF storm have been reported in a mildly
hypothermic patient (331C).11 Therefore, it cannot be ruled
out that even mild hypothermia could induce an ER pattern
and the development of incessant malignant ventricular
arrhythmias in predisposed patients with possible hereditary
cardiac ion channelopathies.
In both cases, the arrhythmias were completely refractory
to well-known antiarrhythmic drugs such as amiodarone,
beta blockers, magnesium channel blockers, and sodium
channel blockers. In contrast, the repeated VF episodes
responded instantly to intravenous isoproterenol infusion in
both patients. Furthermore, quinidine appeared to be highly
efﬁcient, and it seems that J-wave amplitude correlated with
the ventricular arrhythmia susceptibility and quinidine
sulfate levels.12 In an experimental study, it was demon-
strated that an outward shift in the balance of current, either
by an increased potassium current or impaired calcium
current, would mimic the ER pattern.13 It was shown that
vagal stimulation induced VF and that administration of
isoproterenol and quinidine reversed the arrhythmias.13 In
both our cases, the arrhythmias were primarily seen during
night and early morning with enhanced vagal stimulation. It
seems that ErS is refractory to several known and well-
established antiarrhythmic drugs and catheter ablation.12
Figure 3 Case 2: A: A 12-lead electrocardiogram with an aggressive inferior-lateral ER pattern during hypothermia treatment (red arrow). B: The
electrocardiogram is completely normalized after administration of isoproterenol infusion.
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recent additions, and the underlying disease-causing mech-
anisms are still poorly understood. Several genetic variations
in different ionic channels have been identiﬁed as the under-
lying cause. However, genetic variation in the ANK2
molecule has not previously been associated with ErS.
Although the ANK2 variant (c.9854T4C, p.Ile3285Thr,
NM_001148.4), found in case 1, causes an amino acid
change in a highly conserved position, and in silico programs
predict it to be disease associated, functional studies are
needed to clarify its pathophysiological role. The variant
discovered in case 2 (c.11791G4A, p.Glu3931Lys,
NM_001148.4) has previously been found in 2 unrelated
probands, one of whom experienced recurring ventricular
tachycardia and the other idiopathic VF.9 Functional studies
suggest that this variant could be disease causing.9
ANK2 plays a key role in cell physiology: organization of
cardiac proteins and regulation of cardiac electrophysiological
genesis. Humans with ANK2 mutations display varying
degrees of cardiac dysfunction including bradycardia, sinus
arrhythmia, idiopathic VF, polymorphic ventricular tachycar-
dia, and an increased risk of sudden death. A loss-of-function
mutation in ankyrin-2 has initially been described as type 4
long QT syndrome. However, a prolonged rate-corrected QT
interval is not a consistent feature with ANK2 mutations,
indicating that dysfunction of ankyrin-2 represents a clinical
entity distinct from classic long QT syndromes.14 This is
supported by the 2 present cases without QT prolongation.
Conclusion
In patients with idiopathic VF storm with an intermittent ER
pattern, the underlying cellular arrhythmogenic mechanism
could be due to variations in ANK2. However, study of more
cases with similar ER pattern and proven disease-causing
ANK2 variants are needed to conﬁrm this hypothesis. Further
research could resolve the underlying mechanism and the vital
function of the ANK2 molecule in the heart.Acknowledgments
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